Neuropsychology

Published on 12/04/2015 by admin

Filed under Neurology

Last modified 12/04/2015

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 3945 times

Chapter 34 Neuropsychology

Neuropsychology is the scientific study of neural correlates for cognition and behavior, with a specific clinical interest in patients presenting a range of medical, neurological, and psychiatric illnesses. Neuropsychologists are specialized clinicians who receive extended fellowship training (with available board certification) in functional neuroanatomy, neurobiology, psychopharmacology, neurological illness or injury, neuroimaging, personality and mood testing, clinical psychology, and neuropsychological assessment. Neuropsychological evaluation refines neuroimaging and neurological examinations by determining the extent to which cognition is affected by brain dysfunction and by assisting the neurologist in objectively quantifying cognition and behavior. A complete clinical neurological examination would be lacking if it did not consider the patient’s decision-making ability, judgment, attention, memory, language, and the effect changes in these domains can have on functional capacity. Detailed cognitive evaluation can contribute to diagnosis and prognosis, treatment planning, and the ability to monitor changes over time.

In this chapter, we begin by explaining the utility of neuropsychology and describing the neuropsychological evaluation. Guidelines are then suggested for brief cognitive screening in clinical settings. Finally, the typical patterns of cognitive impairments associated with major neurological disorders are discussed.

Goals of Neuropsychology

When neural damage is present or cognitive changes are observed or reported during clinical evaluation, an extended neuropsychological evaluation is appropriate. The prominent neuropsychologist, Arthur Benton (1975), best described neuropsychology as “a refinement of clinical neurological observation [that] serves the function of enhancing clinical observation [and] is closely allied to clinical neurological evaluation and in fact can be considered to be a special form of it.” (p. 68) In clinical settings, neuropsychological assessment aims to extend the clinical neurological exam by: (1) providing important diagnostic information and predictions, even in conditions not detected via other procedures (e.g., anoxia), (2) attributing cognitive strengths and weaknesses to their appropriate factors (e.g., psychiatric symptoms, neurological disease, demographic factors), (3) predicting functional ability to enhance treatment planning, and (4) monitoring cognitive changes and treatment effectiveness across time (Lezak et al., 2004). Neuropsychological assessment is also used in forensic settings and for research in neuroscience, but discussion on these topics is beyond the clinical focus of this chapter.

Before the advent of neuroimaging in the 1970s and 1980s, one of the main goals of neuropsychology was lesion localization. Since current structural imaging techniques are capable of localizing lesions with remarkable accuracy, the focus of neuropsychology has shifted toward characterizing patients’ cognitive and behavioral profiles. Such profiles can be used to make differential diagnosis decisions, especially when lesions may not be evident. For example, some types of dementias present with a cortical profile (i.e., impairments of memory and language), whereas others present with a characteristic subcortical profile (i.e., impairments of processing speed, executive functioning, and mood) (Table 34.1). Repeated neuropsychological evaluations can also be a sensitive method for monitoring the progression of neurodegenerative diseases over time (e.g., Huntington disease [HD], Alzheimer disease [AD]), recovery after an acute injury (e.g., stroke or traumatic brain injury [TBI]), or postoperative recovery following neurosurgery (e.g., temporal lobectomy). Evaluating the effectiveness of medical procedures also entails repeated assessment of cognitive abilities with pre- and post-treatment testing.

Table 34.1 Neuropsychological Characteristics of Cortical versus Subcortical Dementia Using Alzheimer Disease and Huntington Disease as Examples

  Alzheimer Disease
(Cortical Dementia)
Huntington Disease
(Subcortical Dementia)
LEARNING AND MEMORY
Episodic memory Impaired encoding/consolidation Impaired information retrieval
Poor delayed recall and recognition memory Recognition memory is better than delayed recall
Retrograde amnesia Severe, temporally graded, retrograde amnesia Mild, non-graded, retrograde amnesia
Priming Impaired Preserved
Implicit procedural/motor learning Preserved Impaired
Implicit cognitive skill learning Preserved Impaired
ATTENTION/CONCENTRATION Relatively preserved Poor auditory and visual attention
PROCESSING SPEED Relatively intact Very slow
EXECUTIVE FUNCTIONING
Set shifting Better able to shift focus Difficulty with perseveration
Working memory Mild deficits in ability to manipulate information, but preserved phonological loop and visuospatial sketchpad Early notable deficits in phonological loop, visuospatial sketchpad, and ability to manipulate information
LANGUAGE AND SEMANTIC KNOWLEDGE
Speech Preserved Dysarthric and slow
Fluency More impaired semantic fluency than phonemic fluency Severe and equal impairment in phonemic and semantic fluency
Naming Impaired; more semantic errors (e.g., calling a lion “an animal”) Relatively preserved; more perceptual errors (e.g., calling a bucket “a cup”)
Structure of semantic knowledge Tend to focus on concrete perceptual information Able to focus on abstract conceptual knowledge

Adapted from Salmon, D.P., Filoteo, J.V., 2007. Neuropsychology of cortical versus subcortical dementia syndromes. Semin Neurol 27, 7-21.

Another goal of neuropsychology is to attribute cognitive strengths or deficits to their appropriate causes. Whereas neurological disease might account for some cognitive deficits, so can demographic factors (e.g., age, education, race, cultural background), psychiatric symptoms (e.g., depression, anxiety), and other medical conditions (e.g., chronic obstructive pulmonary disease [COPD], alcoholism, hypoglycemia). Therefore, the neuropsychologist weighs the differential impact of all of these confounding factors in the test performances.

In addition to offering information regarding diagnosis and clinical significance of neuroanatomical dysfunction, the neuropsychological assessment is unique in its ability to address patients’ functional abilities. Clinicians of all disciplines are often called on to assess patients’ abilities to make financial and healthcare decisions, provide supervision, drive a car, and live independently, and neuropsychologists can bring vital information to these decisions. Neuropsychological evaluation can help determine patients’ occupational capacity or when they are able to return to work after an injury. Cognitive assessments may also be used to determine appropriate adjustments to patients’ treatment plans.

Neuropsychological Evaluation

The neuropsychological evaluation is primarily focused on answering the referral question and typically involves a review of patient records, clinical interview, test selection, administration and scoring, test interpretation, diagnosis, and treatment and rehabilitation recommendations. Evaluations may vary in length, given the presenting concerns of the patient. A complete interview covers the onset and course of the patient’s cognitive problems, developmental background, medical and psychiatric history, family medical history, academic performance, vocational achievements, psychosocial functioning, and current functional capacity. Information obtained from collateral sources such as caregivers or spouses about the patient’s medical and psychosocial history can also be critical because some patients lack insight. Besides gathering data, the interview serves two additional goals. One is to develop rapport and educate the patient about his or her role in the evaluation. Oftentimes, patients arrive for appointments expecting to be passive participants, as with a neuroimaging procedure. They need to be educated that their involvement is crucial in collecting valid data that will better inform their healthcare providers. A second goal of the interview is to develop hypotheses about the patient’s cognitive status. Behavioral observations of the patient during the interview and testing are an important source of information that can influence test selection and interpretation.

Test Administration

Two major approaches to neuropsychological evaluation currently dominate the field: the fixed battery approach and the flexible battery approach (Barr, 2008). The fixed battery approach requires that the same tests are administered to every patient in a standardized manner. One example of a fixed battery is the Halstead-Reitan battery (Box 34.1), for which comprehensive norms have been published by Heaton and colleagues (Heaton et al., 1991). An advantage to the fixed battery approach is that the information gathered is comprehensive and systematically assesses multiple domains of cognitive functioning. Additionally, if repeated assessments are available, test scores can be directly compared with baseline information, and tests are well validated and normed. Drawbacks of the fixed battery approach include its length (up to 8 hours), because it may be too long for some patients to tolerate and is difficult to afford with the limited reimbursement schedules in managed care. Furthermore, an extended assessment may not be necessary to address the referral question.

Box 34.1

Heaton Adaptation of Halstead-Reitan Neuropsychological Test Battery

Adapted from Heaton, R.K., Grant, I., Matthews, C.G., 1991. Comprehensive Norms for Expanded Halstead-Reitan Battery: Demographic Corrections, Research Findings, and Clinical Applications. Psychological Assessment Resources, Odessa, Florida.

In contrast to the fixed battery approach, the flexible battery (or hypothesis-driven) approach allows neuropsychologists to develop a test battery based on the referral question, the patient’s history, and the clinical interview. In the flexible battery approach, a brief set of basic tests is initially administered, and additional tests of more specific abilities are used to conduct in-depth follow-up assessments based on each particular patient’s needs. For example, clinicians using the Iowa-Benton method (Tranel, 2008) specifically tailor testing to each patient based on their presenting concern by administering the appropriate portions of a core battery, which are then followed up with tests that assess suspected impairments in more detail (Fig. 34.1). Considerations when selecting tests include age, primary language, level of education, ethnicity/cultural factors, reading level, expected level of global cognitive impairment (to avoid ceiling or floor effects in testing), and physical disabilities (Smith et al., 2008). Although this approach is more tailored to the individual needs of the patient (and is therefore briefer), it can be less comprehensive than the fixed battery approach. Most neuropsychologists’ approaches fall somewhere between the use of a set battery and a completely individualized examination.

image

Fig. 34.1 Example of a flexible battery approach.

(Adapted from Tranel, D., 2008. Theories of clinical neuropsychology and brain-behavior relationships, in: Morgan, J.E., Ricker, J.H. (Eds), Textbook of Clinical Neuropsychology. Taylor & Francis, New York, pp. 25-37.)

Regardless of clinicians’ preferences, all tests are administered according to standardized instructions by neuropsychologists or trained psychometricians. The testing environment requires adequate light, appropriate seating and equipment, and a private office where distractions are controlled so patient performance is optimized. Patients are to bring any assistive devices (e.g., hearing aid, glasses) to the testing session. Specifics on test administration and scoring are beyond the scope of this chapter; the interested reader is referred to the test manuals that accompany most published assessment instruments.

Test Interpretation

Test interpretation requires the integration of neuropsychological test scores with findings from the clinical interview, the patient’s history, the neurological examination, neurophysiology and neuroimaging data, and the relevant literature. Before proper interpretation can be accomplished, however, the raw test scores must be compared to an appropriate reference standard. Several approaches are used in interpreting neuropsychological test scores, including the use of normative data, cut scores, and comparisons with an individual’s own prior testing results.

Neuropsychological test scores are interpreted most often by using group statistics to make inferences about individual patients through the use of normative data, which are typically collected by test developers as a standardization sample. Normative data aid in test interpretation by accounting for variables that are likely to influence test performance (e.g., demographic factors) so that accurate and appropriate conclusions are drawn. Confounding variables are accounted for by stratifying test scores according to gender, age, and/or level of education. An individual’s raw score is compared with the distribution of scores from his or her peer group to determine where it falls within the range of expected performances. Fig. 34.2 and Table 34.2 show a normal distribution and interpretive guidelines for use in neuropsychological interpretation. The usefulness of normative data depends strongly on the size and representativeness of the standardization sample. Clinical interpretation can also be greatly affected by the goodness-of- fit between the individual patient and the standardization sample. For example, it would not be appropriate to make determinations about the test performance of an 82-year-old man with 8 years of education by comparing his test score with those of a group of 40-year-olds with an average of 12 years of education. Furthermore, it is important to use the most recent norms available, because cohort effects may lead to differences between current patients and those from whom data were collected years ago. When appropriate norms are not available, there is a danger of overdiagnosis or underdiagnosis of cognitive impairment. Accurate interpretation of neuropsychological test performance necessarily incorporates information about the sample from which the test norms were developed.

Another approach to test interpretation is through the use of cut scores. Tests that rely on cut scores often measure performances with low base rates or deficits very few healthy people demonstrate. Some tests are fairly straightforward in their capability to measure abilities that are largely intact in normal subjects but impaired in disordered patients. For example, most people are able to bisect a line without difficulty, but patients with left-sided visuospatial neglect typically identify the midpoint of the line to be to the right of center. Other tests, however, are more complex and require more sophisticated analyses to develop valid cut scores. Smith et al. (2008) provide an excellent explanation for how cut scores are useful individual statistics (i.e., test scores) that allow inferences about which diagnostic group a patient is likely to belong to (e.g., AD versus mild cognitive impairment versus healthy). Test validation studies commonly use sensitivity and specificity data and base rate information to calculate likelihood ratios and positive predictive values for individual tests. Likelihood ratios and positive predictive values are differing expressions of the probability that a patient has a particular condition given his or her test score. Smith et al. (2008) put these concepts another way by saying, “the positive predictive value allows for statements such as: ‘Based on the patient having earned a score of y on test z, the probability that this patient has the condition of interest is x.’ ” (p. 47). A common example of the application of cut scores can be found in the use of screening instruments to quickly identify potential impairments. For example, a cut score of 23 on the Mini-Mental State Examination (MMSE) has frequently been used as an indicator of cognitive impairment for dementia. Although cut scores can save time and provide useful heuristics, these scores may miss “true hits” and identify “false positives.”

The comparison of current performance with past test scores is another important component of test interpretation, especially if cognitive decline is suspected. Rarely, however, do individuals have previous test data available for these comparisons. When no previous test scores are available, evidence of the patient’s premorbid intellectual functioning is estimated. Several techniques are available for estimating premorbid intellect. Measures known as hold tests (i.e., cognitive tests that are resistant to neurological insult), such as reading ability measures, are frequently used because they are more resistant to many processes that cause decline in cognitive functioning (Smith-Seemiller et al., 1997). Some common measures of reading ability are the National Adult Reading Test (Nelson, 1982), Wide Range Achievement Test Revision 4 (Wilkinson and Robertson, 2006), and Wechsler Test of Adult Reading (Psychological Corporation, 2001), all of which assess the ability to read irregularly spelled words aloud. In some cases, reading ability measures may not be appropriate estimates, because they are affected by the progression of disease (e.g., dementia) (Cockburn et al., 2000; Taylor, 1999). In such conditions, estimates that use demographic variables (e.g., age, education level, primary occupation) in regression-based formulas to predict premorbid IQ may be more useful (e.g., the Barona formula; see Box 34.2). Similarly, academic records (e.g., college grade point average, achievement tests from middle school) can provide estimates of functioning prior to illness or injury. Most contemporary neuropsychologists use a combination of these strategies, either formally (e.g., Oklahoma Premorbid Intelligence Estimate-3) (Schoenberg et al., 2002) or informally, to arrive at the best estimate of premorbid ability.

Ultimately, feedback about the results of the neuropsychological evaluation, along with diagnostic impressions and treatment recommendations, are communicated to the referring physician. Some form of written report is typical in neuropsychological evaluations, and these tend to vary in length and level of detail (e.g., <1 to 8 pages). Additionally, feedback to the patient can also occur through a brief follow-up appointment or copy of the written report.

Brief Mental Status Examination

Before referring a patient for a neuropsychological evaluation, the neurologist typically has either clinical or historical evidence of cognitive concerns. This might come from patient or collateral report, an informal mental status examination, or a brief objective screening measure of mental status. Although many mental status examinations are conducted in a nonstandard manner, neurologists are encouraged to develop a standardized method of mental status examination so interpretations across time and patients can be reliably made. A few suggested objective screening measures of cognitive functioning that are useful for neurologists to administer are briefly described in this section.

Mini-Mental State Examination

One of the most widely used mental status examinations is the MMSE (Folstein et al., 1975), a 30-point standardized screening tool for assessing orientation, attention, short-term recall, naming, repetition, simple verbal and written commands, writing, and construction (Fig. 34.3). The MMSE has been used in a variety of settings (e.g., community, institutions, general hospital, specialty clinics), with many different neurological and psychiatric conditions (e.g., dementia, stroke, depression), across age ranges, and with different cultural and ethnic subgroups. Demographic variables such as age and education have been shown to systematically influence MMSE scores, so normative data or cut scores should account for these variables. One example of appropriate norms comes from the Epidemiologic Catchment Area study (Crum et al., 1993); these are presented in Table 34.3. Whereas many intact individuals achieve total scores near 30, a cut score of 23 on the MMSE has been shown to have adequate sensitivity and specificity (86% and 91%, respectively) for detecting dementia in community samples (Cullen et al., 2005). However, when working with highly educated patients (i.e., ≥16 years of formal education) a cut score of 27 is recommended. A cut score of 27 has correct classification rate of 90.1% and a likelihood ratio of 9.6, which means that highly educated individuals with cognitive complaints and MMSE scores below 27 are almost 10 times more likely to have dementia than those with scores greater than 27 (O’Bryant et al., 2008). MMSE scores can also track changes across time. Longitudinal studies have found patients with AD show an average annual rate of change of 2.81 points, although change rates are not uniform across illness stages or gender (Chatfield et al., 2007).

image

Fig. 34.3 Mini-Mental State Examination.

(Reprinted with permission from Folstein, M.F., Folstein, S.E., McHugh, P.R., 1975. Mini-Mental State: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12, 189-198.)

Despite its widespread use, the MMSE has some drawbacks. One potential threat to the test’s internal validity is the non-standardized administration of some of the items. Examples of these frequent adaptations of the MMSE include the use of nonorthogonal (i.e., semantically related) word stimuli for registration and recall, nonstandard scoring of serial 7s, and nonstandard inclusion of spelling world backwards. Standard scoring instructions can alleviate some of these problems. Another drawback of the MMSE is that it has “ceiling effects” that can miss cognitive impairments in high-functioning individuals. The MMSE also has difficulty differentiating individuals with mild cognitive impairment (MCI) from controls and those with dementia (Mitchell, 2009). Finally, because this test relies on a single total score, partial administration of the measure (e.g., due to sensory impairments of the patient) provides no information about cognitive status.

Modified Mini-Mental State Examination

Some of the criticisms of the MMSE led to the development of the Modified Mini-Mental State Examination (3MS) (Teng and Chui, 1987), a 15-item extension of the MMSE that assesses orientation (self, time, place), attention (simple and complex), memory (recall and recognition), language (naming, verbal fluency, repetition, following commands, writing), construction, and executive functioning (similarities). It remains relatively brief to administer (10 minutes), and age- and education-corrected normative data are available (Tschanz et al., 2002). Regression-based prediction formulas for the 3MS allow for more accurate assessments of change across time (Tombaugh, 2005). The broader scoring range (0 to 100) has been shown to be more sensitive than that of the MMSE in identifying dementia (McDowell et al., 1997; Tschanz et al., 2002) and other cognitive disorders (Bland and Newman, 2001) in large community samples. A cut score for cognitive impairment is typically 77 (Bland and Newman, 2001; McDowell et al., 1997), and a change of 5 points over the course of 5 to 10 years indicates the presence of clinically meaningful decline (Andrew and Rockwood, 2008).

Montreal Cognitive Assessment

The Montreal Cognitive Assessment (MoCA) was originally developed as a screening tool to correct the MMSE’s insensitivity to MCI (Nasreddine et al., 2005). Executive functioning, immediate and delayed memory, visuospatial abilities, attention, working memory, language, and orientation to time and place are all assessed in this one-page measure (Fig. 34.4). The total score ranges from 0 to 30 points, and a cut score of 26 has demonstrated very good specificity (by correctly identifying 87% of healthy participants) and excellent sensitivity when differentiating MCI (90%) and AD (100%) from healthy comparisons (Table 34.4). More importantly, the positive predictive value of the MoCA was 89% for both MCI and AD. The psychometric properties of the MoCA contrast with the MMSE’s sensitivity of 18% for MCI and 78% for AD (although the MMSE had a specificity of 100% in the same study, meaning it correctly ruled out dementia in all cases) (Fig. 34.5). Studies in Parkinson disease (PD) (Hoops et al., 2009; Nazem et al., 2009) and HD (Videnovic et al., 2010) populations have also shown that the MoCA has promise as a measure sensitive to early stages of different types of dementia. The MoCA has the advantage of assessing more cognitive domains, therefore reducing the likelihood that impairments or disorders would be overlooked (e.g., executive dysfunction, a hallmark symptoms of vascular dementia). Another advantage is that the test is free to clinicians (http://www.mocatest.org) and has been translated into 31 different languages and dialects.

image

Fig. 34.4 Montreal Cognitive Assessment.

(Reprinted with permission from Nasreddine, Z.S., Phillips, N.A., Bedirian, V., et al., 2005. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 53, 695-699.)

image

Fig. 34.5 Means and standard deviations for the Mini-Mental State Examination and Montreal Cognitive Assessment for individuals with mild cognitive impairment, Alzheimer disease, and healthy comparisons.

(Reprinted with permission from Nasreddine, Z.S., Phillips, N.A., Bedirian, V., et al., 2005. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 53, 695-699.)